Resources

Cryptosporidiosis has been recognized as one of the leading causes of morbidity and mortality from diarrhea in children under 5 years of age in low-resource settings. Despite the magnitude and significance of the problem, only a single drug is approved to treat Cryptosporidium infection, and new therapies are urgently needed.The third Symposium on Innovative Therapeutics for Cryptosporidium puts the spotlight on Crypto. Similar to the first two meetings hosted by PATH in San Francisco, California (2016) and Seattle, Washington (2018), this convening assembles leading researchers to present and discuss the current state of work on Crypto— from early discovery to clinical development and commercialization, veterinary medicine, diagnostics, and vaccines. Our goal is to share research, highlight opportunities for collaboration, and spark innovation toward making new and improved therapies a reality. This document summarizes the event's scientific program.

A reliable supply chain is often referred to as the “backbone” of a health system. In addition to meeting the demand for drugs and medical supplies, it serves to safeguard a country’s investments in health commodities, which is particularly important as countries ramp up efforts to work toward universal health coverage.The aim of this Journey of the Pill assessment is to identify strengths and inefficiencies in the supply chain in Ghana. It builds on PATH’s earlier supply chain assessment in Kenya. Further defining the journey of medicines will help inform the Ministry of Health and other stakeholders of future actions to strengthen commodity security for noncommunicable diseases.

The results of a continuing collaboration between PATH and Quansys Biosciences

Noncommunicable diseases (NCDs) are a leading cause of death both globally and in Ghana. PATH is working with the Ministry of Health, Ghana Health Service, and Access Accelerated to improve access to NCD screening, diagnosis, and care in the country. As part of this effort, PATH conducted a landscape assessment between November 2019 and January 2020 to understand Ghana's NCD ecosystem as foundational work to inform future investments aligned with the national policy.

The PATH Microarray Center of Excellence (MAP CoE) created a global map tracking known microarray patch developers around the world. This map can be reused as noted in the Creative Commons.